首页> 美国卫生研究院文献>Scientific Reports >Relapsing-Remitting Multiple Sclerosis diagnosis from cerebrospinal fluids via Fourier transform infrared spectroscopy coupled with multivariate analysis
【2h】

Relapsing-Remitting Multiple Sclerosis diagnosis from cerebrospinal fluids via Fourier transform infrared spectroscopy coupled with multivariate analysis

机译:傅里叶变换红外光谱结合多变量分析从脑脊液中复发型-多发性硬化症的诊断

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Multiple sclerosis (MS) is a chronic, progressive, inflammatory and degenerative disease of central nervous system. Here, we aimed to develop a method for differential diagnosis of Relapsing-Remitting MS (RRMS) and clinically isolated syndrome (CIS) patients, as well as to identify CIS patients who will progress to RRMS, from cerebrospinal fluid (CSF) by infrared (IR) spectroscopy and multivariate analysis. Spectral analyses demonstrated significant differences in the molecular contents, especially in the lipids and Z conformation of DNA of CSF from CIS, CIS to RRMS transformed (TCIS) and RRMS groups. These changes enables the discrimination of diseased groups and controls (individuals with no neurological disease) from each other using hierarchical cluster and principal component analysis. Some CIS samples were consistently clustered in RRMS class, which may indicate that these CIS patients potentially will transform to RRMS over time. Z-DNA band at 795 cm−1 that is existent only in diseased groups and significant increase in carbonyl amount, decrease in amideI/amide II and lipid/protein ratios observed only for RRMS groups can be used as diagnostic biomarkers. The results of the present study shed light on the early diagnosis of RRMS by IR spectroscopy complemented with multivariate analysis tools.
机译:多发性硬化症(MS)是中枢神经系统的一种慢性,进行性,炎性和变性疾病。在这里,我们旨在开发一种鉴别诊断复发缓解型MS(RRMS)和临床孤立综合征(CIS)患者的方法,并通过红外线从脑脊液(CSF)中识别出将发展为RRMS的CIS患者( IR)光谱和多元分析。光谱分析表明,从CIS,CIS到RRMS转化的(TCIS)和RRMS组,CSF的分子含量,尤其是脂质和Z构象的DNA差异很大。这些变化使您能够使用层次聚类和主成分分析来区分患病人群和对照(无神经系统疾病的个体)。某些CIS样本始终被归类为RRMS类,这可能表明这些CIS患者随着时间的推移可能会转化为RRMS。 795 diseasecm -1 处的Z-DNA条带仅在患病组中存在,并且羰基量显着增加,酰胺I /酰胺II的降低以及脂质/蛋白质比仅在RRMS组中可见。诊断生物标志物。本研究的结果为补充多变量分析工具的IR光谱对RRMS的早期诊断提供了启示。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号